Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wuling Capsule for Chronic Tinnitus with Emotional Disorder
NCT03674853Completed
- Sponsor
- Xijing Hospital
- Start
- Jun 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of wulingshen in tinnitus (2 arms), sponsored by Xijing Hospital. Primary endpoint: change of severity of tinnitus at 8 weeks. Started Jun 2018; status: completed.
02
Drugs
wulingshen
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT03674853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03674853.